Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04867278 · ClinicalTrials.gov registry record · NA

Heterotopic Ossification Prophylaxis

A NA study, sponsored by University of Maryland, Baltimore.

Completed
Registry status
NA
Development phase
117
Enrollment target

NCT04867278 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 117 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04867278, a NA study, has completed, sponsored by University of Maryland, Baltimore.

COMPLETED
Registry status
NA
Development phase
117 participants
Enrollment target

Study Summary

One complication that can occur after surgery on the acetabulum is the development of bone in abnormal places such as muscle and soft tissues. There is some evidence that a single dose of radiation to the surgical site within 3 days of surgery will prevent this abnormal bone from forming. However, there are no high quality studies proving that radiation works any better than doing nothing at all. The purpose of our study is to determine whether there is a difference in abnormal bone formation after acetabular surgery when patients are treated with external beam irradiation versus no treatment.

Interventions

  • PROCEDURE Debridement
  • PROCEDURE External Beam Radiation (XRT)

Trial Details

FieldValue
Enrollment Target 117 participants
Start Date 2021-05-09
Est. Completion 2023-12-31
Phase NA

Sponsor

University of Maryland, Baltimore

560 total trials

What the Registry Record Tells You About NCT04867278

The ClinicalTrials.gov registry entry for NCT04867278 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Debridement is the first listed.

NCT04867278 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04867278 about?

NCT04867278 is a clinical study titled "Heterotopic Ossification Prophylaxis". One complication that can occur after surgery on the acetabulum is the development of bone in abnormal places such as muscle and soft tissues. There is some evidence that a single dose of radiation to the surgical site within 3 days of surgery will prevent this abnormal bone from forming. However, t...

What is the current status of trial NCT04867278?

This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 2021-05-09. Estimated completion is 2023-12-31.

What interventions are being tested in trial NCT04867278?

The interventions under investigation include: Debridement (PROCEDURE), External Beam Radiation (XRT) (PROCEDURE).

Who is sponsoring clinical trial NCT04867278?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.